INDUSTRY PROFILE
Oncology diagnostics develops blood-based and genomic tests to detect and monitor cancer earlier and more precisely. It recruits molecular biologists and bioinformaticians from academia and partners with cancer centers on biomarker and assay research.
MARKET SIZE
$55B
KEY COMPANIES
10
TARGET RESEARCHERS
Molecular biologists and bioinformaticians in liquid biopsy, NGS, methylation analysis, and assay development
KEY COMPANIES
Grail
Guardant Health
Foundation Medicine
Exact Sciences
Natera
Tempus
Freenome
Adaptive Biotechnologies
Caris Life Sciences
Delfi Diagnostics
USE CASES
Liquid-biopsy R&D recruitment
ctDNA-assay validation partnerships
University cancer-genomics collaborations
Bioinformatics talent pipeline
Early-detection clinical-study alliances
TRY IT
Install the CLI and run your first search in under a minute. No account required to explore.
npx sci-buy@latest COPIED